Vitals Health

Potassium-based salt substitutes: who should ask a clinician first

Bottom line

Most salt substitutes swap sodium chloride for potassium chloride. For healthy kidneys it is usually unremarkable. For others it is a question for a clinician.

Vitals Editorial
Contents map of 4 sections: What is actually in the shaker; The warning, in the NIH's own words; Four questions worth answering before you switch; The practical version.
Contents In this article. This article’s 4 section headings, in the order the article takes them.

A salt substitute is a product with an argument built into its name: it promises the job salt does, without the sodium. The most common way to deliver that is to put potassium chloride where sodium chloride used to be. That swap is genuinely useful for many people, unremarkable for most, and a question for a specific group — which is exactly the group that is least likely to be told so at the point of sale.

This is a nutrition and medication question, not a legal one, and nothing here is medical advice. The federal labeling rules below apply nationwide; whether a potassium-based substitute suits you is a clinical decision, and this article’s purpose is to show where the information lives and which questions are worth asking.

What is actually in the shaker

Potassium chloride performs the ionic job that makes salt taste salty, which is why it is used as a functional replacement rather than a flavoring garnish. The trade-off is taste: the FDA notes in the record of its 2026 salt-substitute rule that commenters described a bitter or metallic note, that research supports replacement below certain levels to avoid it, and that the agency expects the use of potassium chloride to be self-limiting for that reason.

None of that is new to the food supply. Salt substitutes containing potassium chloride have been permitted in non-standardized foods for decades — the FDA’s words — and the 2026 rule extends the same permission to standardized foods, without naming any ingredient. What is worth knowing is that the disclosure follows the ingredient wherever it goes:

  • The ingredient list names it. Ingredients are declared by common or usual name in descending order of weight (21 CFR 101.4), and the FDA states that a standardized food made with potassium chloride must declare it as “potassium chloride” or “potassium salt”. Those two phrases mean the same ingredient.
  • Order in the list is a rough magnitude cue, not a dose. An ingredient near the front of the list is present in a larger amount than one near the back; ingredients at 2 percent or less by weight may be grouped at the end after a quantifying statement.
  • Potassium gets a number where it is significant. The FDA’s response to comments says a manufacturer using potassium-based ingredients must declare the required potassium information on the Nutrition Facts label of a food containing two or more percent of the recommended daily intake for potassium per serving.

Two lines to read, then: the ingredient list for the substitute, and the Nutrition Facts panel for the potassium figure when it is there.

The warning, in the NIH’s own words

The Office of Dietary Supplements at the National Institutes of Health keeps a consumer fact sheet on potassium, and it addresses salt substitutes in one short paragraph:

“Potassium is an ingredient in many salt substitutes that people use to replace table salt. If you have kidney disease or if you take certain medications, these products could make your potassium levels too high. Talk to your health care provider before using salt substitutes.”

The condition it is pointing at is hyperkalemia — too much potassium in the blood. The fact sheet explains the mechanism plainly: healthy kidneys remove excess potassium in urine, so potassium from food and beverages has not been shown to cause harm in healthy people with normal kidney function. Where that removal is impaired, or where a medicine slows it, the same intake can accumulate.

The groups the NIH names:

  • Chronic kidney disease. The fact sheet states that people with chronic kidney disease can develop hyperkalemia “even when they consume typical amounts of potassium from food.”
  • Medicines that reduce potassium loss in urine. ACE inhibitors such as benazepril (Lotensin), angiotensin receptor blockers such as losartan (Cozaar), and potassium-sparing diuretics such as amiloride (Midamor) and spironolactone (Aldactone).
  • Other conditions listed: type 1 diabetes, congestive heart failure, liver disease and adrenal insufficiency.
  • And a caveat that applies beyond those groups: “Even in healthy people, getting too much potassium from supplements or salt substitutes can cause hyperkalemia if they consume so much potassium that their bodies can’t eliminate the excess.”

There is a second, opposite risk that the same page describes, and it is the reason this is not a self-management project: loop diuretics such as furosemide (Lasix) and bumetanide (Bumex) and thiazide diuretics such as chlorothiazide (Diuril) and metolazone (Zaroxolyn) increase potassium loss and can cause abnormally low levels. Too little potassium is also a problem — the fact sheet links low intakes to increased blood pressure, calcium loss from bone and a higher risk of kidney stones, and lists constipation, tiredness and muscle weakness among the symptoms, with severe cases also causing an irregular heartbeat. Which direction a person’s potassium tends to move depends on their kidneys, their medicines and their labs. It is not visible from a label.

On amounts: the fact sheet gives adequate intake of 3,400 mg a day for men aged 19 and over and 2,600 mg for women aged 19 and over, and notes that the diets of many people in the United States provide less than the recommended amounts, with total intakes for most people below the recommendation even when food and supplements are combined. It also notes that most dietary supplements provide no more than 99 mg of potassium per serving. That last figure describes a supplement serving, not a spoonful of a cooking ingredient, so it is not a ceiling on how much potassium a salt substitute can deliver — the products are used in different quantities.

Four questions worth answering before you switch

  1. Has anyone told you to limit potassium — or to watch it? If a clinician has, the substitution decision belongs in that conversation, not in the grocery aisle. The FDA’s own record of the comments on its rule describes the concern precisely: some people need to limit both sodium and potassium, which means a lower-sodium product can look appealing for the wrong reason.
  2. Does your medication list contain an ACE inhibitor, an ARB or a potassium-sparing diuretic? Those are the categories the NIH flags as pushing potassium up. Bring the package and the medication list to a pharmacist; that is a faster and more reliable route than reasoning from a label.
  3. Is the substitute for your plate or the shared pot? A household that silently replaces the salt in the kitchen changes everyone’s intake, including the person who has been told to limit potassium. Keep packages identifiable, and tell whoever cooks.
  4. What would you do with the answer? If the plan would be to stop or change a medicine because of a seasoning product, that is the sign the question belongs with the prescriber. The NIH’s advice on interactions is to tell your doctor, pharmacist and other health care providers about the supplements and the prescription or over-the-counter medicines you take.

The practical version

  • For most people with healthy kidneys and no relevant medicines, a potassium-based substitute used as a seasoning is a substitution, not a treatment. It reduces sodium; it does not replace a blood pressure medication.
  • For anyone in the groups above, the product is a question rather than a default. The FDA’s position is that the label carries the information needed to ask that question well — the ingredient list and the potassium declaration.
  • Rinsing, draining and cooking from scratch remain the least complicated ways to cut sodium, and they change nothing about potassium. The label claims, and what each one is allowed to mean, are set out here.
  • If the reason you are shopping for a substitute is the 2026 rule — which lets standardized foods such as bread, cheese and canned vegetables contain salt substitutes from December 14, 2026 — what the rule does and does not require is here. Nothing in it obliges a manufacturer to reformulate, so the product in front of you today is the product in front of you today.

The primary sources behind this piece, and the rest of the library, are collected in the network’s official government resources directory.

This article is educational content for general information only and is not professional advice. It is not medical advice. Do not start, stop or change a medication because of a label claim — potassium levels are measured by a blood test and interpreted by your own clinician, and a package cannot answer that question for you.

Frequently asked questions

Are potassium-based salt substitutes safe for everyone?
No, and the National Institutes of Health says so directly in its consumer guidance: potassium is an ingredient in many salt substitutes, and 'if you have kidney disease or if you take certain medications, these products could make your potassium levels too high. Talk to your health care provider before using salt substitutes.' For people with normal kidney function the agency's general position is that potassium from food and beverages has not been shown to cause harm, because excess is excreted in urine.
Which medications does that warning cover?
The NIH lists angiotensin converting enzyme inhibitors (ACE inhibitors) such as benazepril and angiotensin receptor blockers such as losartan, plus potassium-sparing diuretics such as amiloride and spironolactone, as medicines that decrease the amount of potassium lost in urine and can push levels too high, especially in people who have kidney problems. It also names loop diuretics such as furosemide and bumetanide and thiazide diuretics such as chlorothiazide and metolazone, which do the opposite and can cause abnormally low potassium. Both directions are clinical problems, and neither is something to manage by choosing a seasoning.
How do I tell whether a product contains potassium chloride?
Read the ingredient list. Ingredients are declared by common or usual name in descending order of predominance by weight under 21 CFR 101.4. The FDA states that a standardized food made with potassium chloride must name it as 'potassium chloride' or 'potassium salt', and that a manufacturer using potassium-based ingredients must declare the required potassium information on the Nutrition Facts label of a food containing two or more percent of the recommended daily intake for potassium per serving.

Sources

Each source is a primary or official reference, checked before publication. Links open the original.

  1. National Institutes of Health, Office of Dietary Supplements — Potassium fact sheet for consumers: under a heading on salt substitutes, 'Potassium is an ingredient in many salt substitutes that people use to replace table salt. If you have kidney disease or if you take certain medications, these products could make your potassium levels too high. Talk to your health care provider before using salt substitutes.' On harm: potassium from food and beverages has not been shown to cause harm in healthy people with normal kidney function, because excess is eliminated in urine, but people with chronic kidney disease and those using certain medications can develop hyperkalemia 'even when they consume typical amounts of potassium from food'; examples given are ACE inhibitors and potassium-sparing diuretics, and the page adds type 1 diabetes, congestive heart failure, liver disease and adrenal insufficiency; 'Even in healthy people, getting too much potassium from supplements or salt substitutes can cause hyperkalemia if they consume so much potassium that their bodies can't eliminate the excess.' Adequate intake is 3,400 mg a day for men 19 and over and 2,600 mg for women 19 and over, and most dietary supplements provide no more than 99 mg of potassium per serving (ods.od.nih.gov/factsheets/Potassium-Consumer/)
  2. National Institutes of Health, Office of Dietary Supplements — medications section of the same fact sheet: ACE inhibitors such as benazepril (Lotensin) and angiotensin receptor blockers such as losartan (Cozaar) 'decrease the amount of potassium lost in the urine and can make potassium levels too high, especially in people who have kidney problems'; potassium-sparing diuretics such as amiloride (Midamor) and spironolactone (Aldactone) do the same; loop diuretics such as furosemide (Lasix) and bumetanide (Bumex) and thiazide diuretics such as chlorothiazide (Diuril) and metolazone (Zaroxolyn) 'increase the amount of potassium lost in the urine and can cause abnormally low levels of potassium'; the page advises telling a doctor, pharmacist and other health care providers about supplements and prescription or over-the-counter medicines (ods.od.nih.gov/factsheets/Potassium-Consumer/)
  3. Federal Register, Vol. 91, No. 196 (October 13, 2026) — FDA final rule, 'Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods,' 91 Fed. Reg. 65040 (FR Doc. 2026-20848): in responding to comments about potassium-based substitutes, the FDA says it recognises the need for certain individuals to monitor potassium intake and emphasises the use of label information; that a manufacturer choosing to use potassium-based ingredients must declare the required potassium information on the Nutrition Facts label of a food containing two or more percent of the recommended daily intake for potassium per serving (citing 21 CFR 101.9(c)(8)(ii) and (iii)); and that the ingredient statement must declare 'potassium chloride' or 'potassium salt'; the rule does not limit salt substitutes to potassium-based ingredients, and the agency says it cannot determine how far the food supply's potassium content will change because reformulation is voluntary (federalregister.gov/documents/2026/10/13/2026-20848/use-of-salt-substitutes-to-reduce-the-sodium-content-in-standardized-foods)
  4. 21 CFR 101.4 — food labeling, designation of ingredients: ingredients required to be declared on a label, 'including foods that comply with standards of identity', must be listed by common or usual name in descending order of predominance by weight, with ingredients present at 2 percent or less by weight permitted at the end of the statement after an appropriate quantifying statement (ecfr.gov/current/title-21/section-101.4)
#salt substitutes#potassium chloride#hyperkalemia#kidney disease#food labels#blood pressure